Select Filters
Apply Filters

Investigating Tau Biology and Toxicity in Glia

Oyinkan Adesakin, Ph.D.
Brighton, United Kingdom
2019

Understanding the Impact of a Late-Onset Alzheimer's Disease Mutation in CD2AP on Synapses

Claudia Almeida, Ph.D.
Lisbon, Portugal
2019

Burden and correlates of cognitive performance in Syrian refugees in Jordan

Tala Al-Rousan, MD
San Diego, CA - United States
2019

Hypothalamic dysfunction as a driver of age-related cognitive decline

Ahmad Aziz, M.D., Ph.D.
Bonn, Germany
2019

Glial Control of the Local Neuronal Translatome in Alzheimer's Disease

Jimena Baleriola Gomez De Pablos, Ph.D.
Leioa, Spain
2019

Systemic Inflammation as a Factor to Influence Alzheimer’s Disease

Tatiana Barichello, Ph.D.
Houston, TX - United States
2019

Multimodal Intergenerational Social Contact Intervention (MISCI)

Phaedra Bell, PhD
San Francisco, CA - United States
2019

AD Biomarker and Risk Characterization in Cognitively Unimpaired Middle-Age

Tobey Betthauser, Ph.D.
Madison, WI - United States
2019

Nup153 as target to improve neurogenesis and cognitive function in AD

Claudia Colussi, Ph.D.
Rome, Italy
2019

Telomeres and cognitive decline in subjects at risk of Alzheimer's disease

Marta Crous-Bou, Ph.D.
Barcelona, Spain
2019

Generation of Human Cerebral Organoids to Model Alzheimer’s Disease

Luz Karina Cuanalo Contreras, Ph.D.
Houston, TX - United States
2019

RCT with a Ketone Ester Drink in MCI

Stephen Cunnane, Ph.D.
Sherbrooke, Canada
2019

Insulin resistance and inflammation in Alzheimer's: The role of soluble TNF

Maria Elizabeth De Sousa Rodrigues, Ph.D.
Atlanta, GA - United States
2019

LPC DHA as Novel Nutraceutical Approach for Prevention of Alzheimer Disease

Sugasini Dhavamani, Ph.D.
Chicago, IL - United States
2019

Disruption of 3D-genome structure in Alzheimer’s Disease

Vishnu Dileep, Ph.D.
Cambridge, MA - United States
2019

Burdensome end of life treatments in older adults with advanced dementia

Elizabeth Dzeng, MD, PhD
London, United Kingdom
2019

ACSS2 and the Metabolic-Epigenetic Axis in Alzheimer's Disease

Gabor Egervari, M.D., Ph.D.
Philadelphia, PA - United States
2019

The efficacy of speed of processing training in Mild Cognitive Impairment

Derya Durusu Emek Savas, PhD
Izmir, Turkey
2019

The Alzheimer Café model: a process evaluation study

Christine FitzGerald, PhD
Galway, Ireland
2019

Feasibility : Identification of those who may benefit from Palliative Care

Corrina Grimes, MS
Belfast, Ireland
2019

Building evidence for palliative care for people with prion disease

Krista Harrison, PhD
San Francisco, CA - United States
2019

Identifying Cognitive and Health-Related Biomarkers for Dementia in Congo

Jean Ikanga, Ph.D.
Atlanta, GA - United States
2019

TMEM106b as a lysosomal safeguard of cognitive function

Joanna Jankowsky, Ph.D.
Houston, TX - United States
2019

Music and Dementia

Catherine Jordan, PhD
Dublin, Ireland
2019

Effect of KIBRA on Tau-Mediated Synaptic and Memory Deficits

Grant Kauwe, Ph.D.
Novato, CA - United States
2019

Citizen Brain: Loneliness

Josh Kornbluth
San Francisco, CA - United States
2019

Developing HDAC6 inhibitors as novel therapeutics for Alzheimer's Disease

Janice Kranz, Ph.D.
Cambridge, MA - United States
2019

Study of tau strains to understand the phenotypic diversity in AD

Aurelien Lathuiliere, M.D., Ph.D.
Boston, MA - United States
2019

Sleep, cognitive decline and dementia-a comparison between China and the US

Yue Leng, PhD, MD, MPhil
San Francisco, CA - United States
2019

Age-related hearing loss and neural correlates of visual short-term memory

David Loughrey, PhD
Dublin, Ireland
2019

1 2 3 4 5 6 7 8 9 10... >|